Log in
Sign up
BillionToOne

BillionToOne

A diagnostic DNA testing company using quantified biological data.

OverviewStructured DataIssuesContributorsActivity
Contents

Founded in 2016 by Dave Tsao, Oguzhan Atay, and Sukrit Silas, BillionToOne is a DNA diagnostic company originating from Y Combinator's S17 accelerator batch. It is located in Palo Alto, California, and uses diagnostic DNA testing that quantifies molecular level bodily changes.

COVID-19 Response

BillionToOne received emergency use authorization from the Food and Drug Administration (FDA) in 2020, for its SARS-CoV-2 test that removes the process of Ribo Nucleic Acid (RNA) extraction, a time-consuming step in COVID-19 testing. BillionToOne developed a COVID-19 testing method called the qSanger-COVID-19 assay. It uses different instrument sets and chemicals than other methods that were applied in 2020. BillionToOne partnered with SwiftBiosciences to manufacture the COVID-19 assay kits and began international distribution in May of 2020.

qSanger

qSangerTM technology is a patent-pending test developed by BillionToOne that works to detect viral RNA. It is based on the technology in Sanger sequencing, a DNA testing method that determines the nucleotide sequence in DNA molecules, also known as the "chain termination method."

Timeline

July 12, 2021
BillionToOne closes $55,000,000 Series B Funding round led by Hummingbird Ventures and Four Rivers Group with participation from Neotribe Ventures, Norwest Venture Partners, Y Combinator, and Libertus Capital.

Funding Rounds

Open in Query Tool

Products

Open in Query Tool

Acquisitions

Open in Query Tool

SBIR/STTR Awards

Open in Query Tool

Patents

Open in Query Tool

Further Resources

Title
Author
Link
Type
Date

BillionToOne Announces Groundbreaking New COVID-19 Test Unlocking One Million Daily Tests

PR Newswire

https://finance.yahoo.com/news/billiontoone-announces-groundbreaking-covid-19-140000160.html

Web

April 7, 2020

BillionToOne Molecular Counting Technology (2019)

Oguzhan Atay

https://vimeo.com/311952506

Web

January 17, 2019

BillionToOne, Inc. and Eluthia Launch UNITYTM Test, the First Non-Invasive Prenatal Test for Cystic Fibrosis, Spinal Muscular Atrophy and Hemoglobinopathies in Germany, Austria, Switzerland and the Netherlands

BillionToOne, Inc

https://www.prnewswire.com/news-releases/billiontoone-inc-and-eluthia-launch-unity-test-the-first-non-invasive-prenatal-test-for-cystic-fibrosis-spinal-muscular-atrophy-and-hemoglobinopathies-in-germany-austria-switzerland-and-the-netherlands-300949545.html

Web

October 31, 2019

BillionToOne, Inc., announced today that it has closed its follow-on Series A+ funding round of $15 million

BillionToOne, Inc

https://www.prnewswire.com/news-releases/billiontoone-inc-announced-today-that-it-has-closed-its-follow-on-series-a-funding-round-of-15-million-301020957.html

Web

March 10, 2020

Diagnostics firm claims to have potential for 1 million COVID-19 tests per day

https://www.med-technews.com/news/diagnostics-firm-hopes-to-have-unlocked-1-million-covid-19-t/

Web

April 15, 2020

References

billiontoone.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Molecular diagnostics
Molecular diagnostics
Healthcare
Healthcare
DNA
DNA
‌
Genetic testing
Digital health
Digital health
Medical diagnostics
Medical diagnostics
...
Location
Menlo Park, California
Menlo Park, California
Palo Alto, California
Palo Alto, California
United States
United States
B2X
B2B
B2B
CEO
Oguzhan Atay
Oguzhan Atay
Founder
Oguzhan Atay
Oguzhan Atay
‌
Sukrit Silas
‌
Dave Tsao
Pitchbook URL
pitchbook.com/profiles...156479-77
Legal Name
BillionToOne, Inc.
Accelerator
Y Combinator
Y Combinator
Accelerator Batch
‌
Y Combinator S17 Batch
Legal classification
Corporation
Corporation
Date Incorporated
January 2016
Number of Employees (Ranges)
201 – 500
Full Address
1035 O’Brien Drive Menlo Park, CA 94025
1455 Adams Drive Suite 1110 Menlo Park, CA 94025 United States
Place of Incorporation
Delaware
Delaware
Investors
‌
NewDo Venture
‌
Friále
Hummingbird Ventures
Hummingbird Ventures
Baillie Gifford
Baillie Gifford
David Chan
David Chan
Libertus Capital
Libertus Capital
Wei Guo
Wei Guo
Norwest Venture Partners
Norwest Venture Partners
...
DUNS Number
080596376
Founded Date
January 2016
Email Address
info@billiontoone.com
Phone Number
+16504602551
Fax Number
+1 (833) 915-0146
Total Funding Amount (USD)
276,020,000
Latest Funding Round Date
December 2022
Competitors
Lucence
Lucence
Cepheid
Cepheid
Human Longevity Inc.
Human Longevity Inc.
Helix (company)
Helix (company)
Lazarus Bioscience
Lazarus Bioscience
Business Model
Commerce
CTO
David Tsao
David Tsao
Key People
Oguzhan Atay
Oguzhan Atay
David Tsao
David Tsao
Latest Funding Type
‌
Series C round
Patents Assigned (Count)
1
Motto/Tagline
We push the boundaries of molecular diagnostics through quantitative technologies.
Wellfound ID
billiontoone
Technologies Used
MailGun
MailGun
Slack
Slack
Zoom (company)
Zoom (company)
Gmail
Gmail

Other attributes

Company Operating Status
Active
Country
United States
United States
Funding Round Investor
500 Global
500 Global
Latest Funding Round Amount (USD)
48,500,000
Y Combinator URL
ycombinator.com/compani...iontoone

Find more companies like BillionToOne

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
Company
HomePress & MediaBlogCareers
We're hiring
Products
Knowledge GraphQuery ToolData RequestsKnowledge StorageAPIPricingEnterpriseChatGPT Plugin
Legal
Terms of ServiceEnterprise Terms of ServicePrivacy Policy
Help
Help centerAPI DocumentationContact Us
By using this site, you agree to our Terms of Service.